Table 1a:
Patient characteristics by dietary pattern
| Prudent Diet | Western Pattern | |||
|---|---|---|---|---|
| Low (N=116) | High (N=117) | Low (N=116) | High (N=117) | |
| Age: Mean±SD [range], y | 59±11 [25–95] | 62±11 [39–92] | 62±12 [30–95] | 59±10 [25–92] |
| Sex, N (%) | ||||
| Male | 89 (79.72) | 82 (70.09) | 77 (66.38) | 94 (80.34) |
| Female | 27 (23.28) | 35 (29.91) | 39 (33.62) | 23 (19.66) |
| Race | ||||
| White | 109 (93.97) | 114 (97.44) | 112 (96.55) | 111 (94.87) |
| Black | 3 (2.59) | 1 (0.85) | 1 (0.86) | 3 (2.56) |
| American Indian | 3 (2.59) | 1 (0.85) | 1 (0.86) | 3 (2.56) |
| Other | 1 (0.86) | 1 (0.85) | 2 (1.72) | 0 (0.00) |
| Education | ||||
| Less than High School | 10 (8.70) | 6 (5.13) | 9 (7.83) | 7 (5.98) |
| High School/GED | 46 (40.00) | 25 (21.37) | 36 (31.30) | 35 (29.91) |
| Some College | 42 (36.52) | 45 (38.46) | 40 (34.78) | 47 (40.17) |
| 4-yr Degree | 10 (8.70) | 15 (12.82) | 11 (9.57) | 14 (11.97) |
| More than 4-yr Degree | 7 (6.09) | 26 (22.22) | 19 (16.52) | 14 (40.17) |
| BMI: Mean±SD [range], kg/m2 | 26.93±6.02 [16.01–47.94] |
28.15±5.53 [16.44–54.36] |
27.17±5.29 [16.01–40.21] | 27.92±6.26 [16.02–54.36] |
| Stage, N (%) | ||||
| 1 | 16 (13.79) | 19 (16.24) | 18 (15.52) | 17 (14.53) |
| 2 | 15 (12.93) | 17 (14.53) | 17 (14.66) | 15 (12.82) |
| 3 | 18 (15.52) | 18 (15.38) | 17 (14.66) | 19 (16.24) |
| 4 | 67 (57.76) | 63 (53.85) | 64 (55.17) | 66 (56.41) |
| Site, N (%) | ||||
| Larynx | 21 (18.10) | 22 (18.80) | 14 (12.07) | 29 (24.79) |
| Oral Cavity | 50 (43.10) | 53 (45.30) | 55 (47.41) | 48 (41.03) |
| Oropharynx | 42 (36.21) | 40 (34.19) | 45 (38.79) | 37 (31.62) |
| Hypopharynx | 3 (2.59) | 2 (1.71) | 2 (1.72) | 3 (2.56) |
| HPV Status, N (%) * | ||||
| Positive | 40 (34.48) | 33 (28.21) | 49 (42.24) | 58 (49.57) |
| Negative | 50 (43.10) | 57 (48.72) | 39 (33.62) | 34 (29.06) |
| Invalid/Missing | 26 (22.41) | 27 (23.08) | 28 (24.14) | 25 (21.37) |
| ACE-27 Score, N (%) | ||||
| None | 33 (28.70) | 32 (27.35) | 27 (23.48) | 38 (32.48) |
| Mild | 59 (51.30) | 56 (47.86) | 60 (52.17) | 55 (47.01) |
| Moderate | 16 (13.91) | 17 (14.53) | 18 (15.65) | 15 (12.82) |
| Severe | 7 (6.09) | 12 (10.26) | 10 (8.70) | 9 (7.69) |
| Drinking Status, N (%) | ||||
| Never | 9 (7.76) | 9 (7.69) | 11 (9.48) | 7 (5.98) |
| Current | 80 (68.97) | 84 (71.79) | 75 (64.66) | 89 (76.07) |
| Former (quit >12 months) | 27 (23.28) | 24 (20.51) | 30 (25.86) | 21 (17.95) |
| Smoking, N (%) | ||||
| Never | 30 (25.86) | 27 (23.08) | 36 (31.03) | 21 (17.95) |
| Current | 55 (47.41) | 38 (32.48) | 41 (35.34) | 52 (44.44) |
| Former (quit >12 months) | 31 (26.72) | 52 (44.44) | 39 (33.62) | 44 (37.61) |
| Treatment Modality, N (%) | ||||
| Surgery Alone | 28 (24.14) | 30 (25.64) | 29 (25.00) | 29 (24.79) |
| Surgery + Adj rad | 17 (14.66) | 19 (16.24) | 16 (13.79) | 20 (17.09) |
| Surgery + Adj chemorad | 14 (12.07) | 14 (11.97) | 16 (13.79) | 12 (10.26) |
| Radiation Alone | 10 (8.62) | 6 (5.13) | 7 (6.03) | 9 (7.69) |
| Chemorad Alone | 38 (32.76) | 38 (32.48) | 40 (34.48) | 36 (30.77) |
| Chemo Alone | 1 (0.86) | 3 (2.56) | 1 (0.86) | 3 (2.56) |
| Palliative, Unknown | 8 (6.90) | 7 (5.98) | 7 (6.03) | 8 (6.84) |
| Deceased, N (%) | 33 (28.45) | 32 (27.35) | 30 (25.86) | 35 (29.91) |
*
one patient missing ACE-27 score
Abbreviations: ACE-27, Adult Comorbidity Evaluation-27; BMI, body mass index; HPV, human papillomavirus; SD, standard deviation.